Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Characterization of potential outcome measures for future clinical trials in fragile X syndrome.
Fragile X syndrome and targeted treatment trials.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Fragile X syndrome and targeted treatment trials.
Fragile X syndrome and targeted treatment trials. Results Probl Cell Differ. 2012; 54:297-335.
View in:
PubMed
subject areas
Animals
Anti-Bacterial Agents
Antioxidants
Baclofen
Brain-Derived Neurotrophic Factor
Central Nervous System Stimulants
Clinical Trials as Topic
Dendritic Spines
Dopamine
Enzyme Inhibitors
Fragile X Mental Retardation Protein
Fragile X Syndrome
Humans
Indans
Lithium Compounds
Melatonin
Mice
Mice, Knockout
Minocycline
Nootropic Agents
Piperidines
Receptor, Metabotropic Glutamate 5
Receptors, GABA
Receptors, Metabotropic Glutamate
Signal Transduction
Vitamin E
authors with profiles
Elizabeth Berry-Kravis